Lunaphore brings together the spatial biology community at AACR 2024 to mark innovations in cancer research

Lunaphore brings together the spatial biology community at AACR 2024 to mark innovations in cancer research

MINNEAPOLIS, MN and LAUSANNE, Switzerland – March 21, 2023 – Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brand, Lunaphore, will host an in-person symposium at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place in San Diego from April 5-10, to discuss the recent paradigm shift in cancer research, driven by innovative spatial technologies. Lunaphore will present the transformative impact of the recently launched, fully automated, same-section spatial multiomics application accelerating translational research.

An international group of leading experts will explore how the breakthrough research enabled by Lunaphore’s end-to-end COMET™ product portfolio is paving the way for novel personalized immuno-oncology therapies. The symposium aims to promote interactions between researchers and prominent innovators from industry and academia and presents a unique opportunity for fostering collaborations.

Lunaphore will also reveal upcoming feature releases, further enhancing COMET capabilities for specific research needs and broadening its applications. These enhancements will ensure the quantitative detection of essential biomarkers with minimal antibody concentrations for customized hyperplex assays, ultimately redefining cancer research.

Dinner Symposium details:

Spatial biology: reinvent cancer research with multiomics and innovative workflows

Location: Hard Rock Café Hotel San Diego (Adjacent to conf. center)

Date & Time: April 8, 2024 | 6:30 PM PST

Confirmed guest speakers:

Jared Burks, Ph.D. Professor, Co-Director of the Flow Cytometry & Cellular Imaging Core Facility, University of Texas, MD Anderson Cancer Center (USA)

Sammy Ferri-Borgogno, Ph.D., Instructor, The University of Texas MD Anderson Cancer Center

Free registration:

In addition, during the conference, Dr. Karuna Ganesh MD, Ph.D., Assistant Member and Medical Oncologist, Memorial Sloan Kettering Cancer Center, will highlight her work on the role of plasticity during tumorigenesis facilitated by the COMET™ platform during the Bayard Clarkson Symposium, taking place on Monday, April 8 from 10:15 to 11:45.

Two poster presentations will also showcase novel datasets highlighting the industry-leading capabilities of Lunaphore’s solutions to advance cancer research.

Poster presentation details:

Unveiling the spatial dynamics of the tumor microenvironment: integrated RNA and protein profiling on the same slide through automated spatial multiomics analysis

Poster number: 3797

Date & Time: Monday, April 8 | 1:30 PM – 5:00 PM

Presenter: Arec Manoukian, Ph.D. Application Development Scientist, Lunaphore


HOST-Factor: A comprehensive platform for single-cell highplex immunofluorescence staining, digital imaging, spatial mapping, and quantitative analysis of the tumor microenvironment

Poster number: 28. Section: 10

Date & Time: Tuesday, April 9 | 1:30 PM – 5:00 PM

Presenter: Janusz Franco-Barraza, Ph.D., Research Assistant Professor, Manager of  Spatial Immuno-Proteomics Facility, Fox Chase Cancer Center (USA).


During the conference, Lunaphore’s scientists will be available at booth #415 to provide live demonstrations of the COMET system and access to raw data on various cancer types.

To book a meeting, learn more about Lunaphore’s presence at the conference, and view the full list of posters or presentations showcasing our technologies, please visit Lunaphore’s website.


About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

About Lunaphore

Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit

About COMET™

COMET™ is the only fully automated, high-throughput, hyperplex platform ensuring scalability and reproducibility without the need to conjugate primary antibodies. COMET™ provides walk-away automation, integrating staining, imaging, and image preprocessing steps to obtain standard hyperplex images. The multiomics capability of COMET™ enables the simultaneous analysis of both RNA and protein data within the spatial context of tissues to enhance the understanding of cellular dynamics and disease processes. COMET™ generates highly robust and reproducible data with full tissue preservation, allowing researchers to perform downstream modalities such as H&E or transcriptomics using the same slide. Its superior tissue profiling capabilities facilitate the analysis of 40 different spatial markers in each automated run on a tissue slide. In contrast to other spatial biology solutions, COMET™ works with off-the-shelf, label-free primary antibodies, making panel design much more flexible and faster than any other hyperplex solution. COMET™ works with regular glass slides from standard histology workflows; it is validated for human and mouse samples and is compatible with any other animal sample. The platform can be used for a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology. To learn more about the COMET™ platform, please visit:


For further information on Lunaphore:

Lindsey Rodger, Head of Communications
[email protected]


Bio-Techne Corporation (NASDAQ: TECH)

David Clair, Vice President, Investor Relations & Corporate Development
[email protected]